Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Debt / NOTE 4.000% 2/0
-
Market price (% of par)
-
95.97%
-
Total 13F principal
-
$258,042,517
-
Principal change
-
-$44,285,483
-
Total reported market value
-
$248,212,246
-
Number of holders
-
37
-
Value change
-
-$42,800,208
-
Number of buys
-
18
-
Number of sells
-
16
Institutional Holders of PDL BIOPHARMA INC - NOTE 4.000% 2/0 as of Q4 2014
As of 31 Dec 2014,
PDL BIOPHARMA INC - NOTE 4.000% 2/0 was held by
37 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$258,042,517
in principal (par value) of the bond.
The largest 10 bondholders included
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, ADVENT CAPITAL MANAGEMENT /DE/, AQR CAPITAL MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, PIONEER INVESTMENT MANAGEMENT INC, BASSO CAPITAL MANAGEMENT L.P., ZAZOVE ASSOCIATES LLC, WOLVERINE ASSET MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
38
institutional bondholders reporting positions
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.